OUTCOMES OF TREATMENT REFRACTORY AND RELAPSED HODGKIN LYMPHOMA WITH AUTOLOGOUS STEM CELL TRANSPLANTATION (LITERARY REVIEW)
Hodgkin lymphoma is the most common cancer in children, adolescents, and young adults. Overall survival is approximately 80% to 90%. A subset of these patients has refractory disease or experience disease relapse. Conventional salvage therapies and autologous stem-cell transplantation is usually considered the standard of care for these patients. Our analysis reports outcomes in these patients.
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.